Collaborative Research Development Grant
Launched in 2004, this grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution(s) in which the recipients will conduct the research.
2024 Grant Recipients
-
Alberto Ciccia, PhD,
Columbia University
Defining the impact of DNA repair variants on immune-based therapy of ovarian cancer at scale
-
Selvendiran Karuppaiyah, PhD,
The Ohio State University
Identification of early molecular events and a novel biomarker for high grade serous ovarian cancer
-
Bethany Hannafon, PhD,
University of Oklahoma Health Sciences Center
Development of a novel DCLK1-targeted CAR-T to prevent ovarian cancer metastatic recurrence
2023 Grant Recipients
-
Kristopher Sarosiek, PhD,
Targeting Apoptotic Vulnerabilities in Ovarian Cancer
-
Simon Gayther, PhD,
Cedars-Sinai Medical Center
iPSC Modeling of Ovarian Cancers in BRCA1 and 2 Mutation Carriers
2022 Grant Recipients
-
Jen-Tsan Chi, MD, PhD,
Duke University
The Role of Ferroptosis in the Metastatic Ovarian Cancer
-
Ronald Buckanovich, MD, PhD,
Magee-Womens Research Institute
Role of Macrophage-secreted BIGH3 in Tumor Immunity
-
Benjamin Bitler, PhD,
University of Colorado - Denver
A Machine Learning Approach to Chemotherapy-induced Remodeling of the Tumor
2021 Grant Recipients
-
Martin Cannon, PhD,
University of Arkansas for Medical Sciences
Understanding and Targeting Myeloid Populations in Ovarian Cancer
-
Ivan Ahel, PhD,
University of Oxford
Exploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
2020 Grant Recipients
-
Andrew K. Godwin, PhD,
University of Kansas Medical Center Research Institute
Tumor-Derived Extracellular Vesicle in Ovarian Cancer
-
Sohrab Shah, PhD,
Memorial Sloan Kettering Cancer Center
Profiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment
-
Ugo Cavallaro, PhD,
Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Fondazione Monzino
Interplay Between Ovarian Cancer Stem Cells and the Tumor Microenvironment
-
Sandra Orsulic, PhD,
UCLA School of Medicine
Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma
2019 Grant Recipients
-
Ronald Buckanovich, MD, PhD,
Magee-Womens Research Institute
Targeting Tumor Desmoplasia to Enhance Immunotherapy
-
Rugang Zhang, PhD,
The Wistar Institute
Developing Epigenetic Therapies for Ovarian Cancer
2018 Grant Recipients
-
Gordon Mills, MD, PhD,
MD Anderson Cancer Center
Rational Combination Therapy in Ovarian Cancer
-
David Sabatini, MD, PhD,
Whitehead Institute for Biomedical Research
A Personalized Approach to Identify and Target Ovarian Cancer Liabilities
2017 Grant Recipients
-
Tyler Curiel, MD,
University of Texas Health Science Center at San Antonio
Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
-
Ronen Marmorstein, PhD,
University of Pennsylvania
Chromatin Regulatory Mechanisms in Ovarian Cancer
-
Kenneth Nephew, PhD,
Indiana University
Epigenetic Vulnerabilities of Ovarian Cancer Stem Cells
-
Ie-Ming Shih, MD, PhD,
Johns Hopkins University School of Medicine
Development of Targeted Therapies for Recurrent Ovarian Cancer
2016 Grant Recipients
-
Beth Y. Karlan, MD,
Cedars-Sinai Medical Center
Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma
-
David Spriggs, MD,
Memorial Sloan Kettering Cancer Center
Novel Approaches to Immunotherapy
2015 Grant Recipients
-
Anna Lokshin, PhD,
University of Pittsburgh
Microenvironmental Control of Premalignant Lesions in Ovarian Cancer
-
Alexander Nikitin, MD, PhD,
Cornell University
Cancer-prone Stem Cell Niches in Ovarian and Tubal Epithelia
-
Michael Yaffe, MD, PhD,
Massachusetts Institute of Technology
Using Functional Genetics and Nanomedicine for Ovarian Cancer Treatments
2014 Grant Recipients
-
Tyler Curiel, MD,
University of Texas Health Science Center at San Antonio
Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
-
Ronen Marmorstein, PhD,
University of Pennsylvania
Chromatin Regulatory Mechanisms in Ovarian Cancer
-
Ursula Matulonis, MD,
Dana Farber Cancer Institute
Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy
2013 Grant Recipients
-
Simon Gayther, PhD,
University of Southern California
Functional Analysis of Genetic Susceptibility Loci to Identify Biomarkers and Candidate Genes Associated with Ovarian Cancer Initiation, Progression and Outcome
-
Anil K. Sood, MD,
MD Anderson Cancer Center
Power of Platelets in Ovarian Cancer
-
Elizabeth Swisher, MD,
University of Washington
The FA-BRCA Pathway and Response to Platinum and PARP Inhibitors in Ovarian, Tubal and Peritoneal Carcinomas
2012 Grant Recipients
-
George Coukos, M.D., Ph.D.,
University of Pennsylvania
Engineering Immune Cells to Better Recognize and Kill Ovarian Cancer
-
Ernst Lengyel, MD, PhD,
University of Chicago
Reprogramming of Ovarian Cancer Microenvironments by miRNAs
-
Martin Matthew Matzuk, MD, PhD,
Baylor College of Medicine
Diagnostic Strategies for Detection of Ovarian Cancer
2011 Grant Recipients
-
Kenneth Nephew, PhD,
Indiana University
A New Approach to Treating Recurrent Ovarian Cancer and Newly Diagnosed Disease
-
Santo Nicosia, MD,
University South Florida
Ovarian Cancer: A Theme Based Approach Toward Identification of Novel Diagnostic and Therapeutic Targets
-
Weiping Zou, MD, PhD,
University of Michigan - Ann Arbor
Understanding how Ovarian Cancer Stem Cells Play a Role in Disease Progression and Drug Resistance
2009 Grant Recipients
-
Andrew Berchuck, MD,
Duke University Medical Center
International Ovarian Cancer Association Consortium: Finding Genetic Markers of Ovarian Cancer Using Polymorphisms
-
Andrew K. Godwin, PhD,
Fox Chase Cancer Center
Understanding the Microenvironment Where Ovarian Cancer Grows as a Target for Treatment
-
Anil K. Sood, MD,
MD Anderson Cancer Center
Novel Treatments for Ovarian Cancer Using siRNAs
2008 Grant Recipients
-
Gary Leiserowitz, MD,
University of California - Davis
The Carbohydrate Components of Cellular Molecules: A New Way to Diagnose Ovarian Cancer?
-
George Coukos, M.D., Ph.D.,
University of Pennsylvania
Engineering T Cells to Augment Natural Immunity to Ovarian Cancer
-
Robert C. Bast Jr., MD,
MD Anderson Cancer Center
Autophagy and Ovarian Cancer
2007 Grant Recipients
-
Kunle Odunsi, MD, PhD,
Roswell Park Cancer Institute
Enhancing Immunity to Ovarian Cancer Tumors
-
Martin Matthew Matzuk, MD, PhD,
Baylor College of Medicine
MicroRNA’s as Diagnostic and Therapeutic Targets in Ovarian Cancer
-
Jonathan S. Berek, MD, MMS,
Stanford University
Leading the Effort to Develop Vaccines and Immunotherapy for Ovarian Cancer
2006 Grant Recipients
-
Bo Rueda, PhD,
Massachusetts General Hospital
Understanding the Key Molecular Pathways that Drive Ovarian Cancer
-
Peter Laird, PhD,
University of Southern California/Keck Medical School
Molecular Changes to DNA that Contribute to Ovarian Cancer
-
Ronny I. Drapkin, MD, PhD,
Dana Farber Cancer Institute
Ovarian Cancer Biomarkers: Identification, Validation and Assessment of Biological Function
2005 Grant Recipients
-
Anil K. Sood, MD,
MD Anderson Cancer Center
Novel siRNA Based Therapeutic Approaches for Ovarian Carcinoma
-
Andrew K. Godwin, PhD,
Fox Chase Cancer Center
Therapeutic Targeting of the Tumor Microenvironment in Ovarian Cancer
-
Andrew Berchuck, MD,
Duke University Medical Center
International Ovarian Cancer Association Consortium
2004 Grant Recipients
-
Carol Aghajanian, MD, PhD,
Memorial Sloan Kettering Cancer Center
Novel Approaches to Ovarian Cancer Treatment